chr13-40559985-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002015.4(FOXO1):c.1506G>A(p.Ser502=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,614,024 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0013 ( 5 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 34 hom. )
Consequence
FOXO1
NM_002015.4 synonymous
NM_002015.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.807
Genes affected
FOXO1 (HGNC:3819): (forkhead box O1) This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 13-40559985-C-T is Benign according to our data. Variant chr13-40559985-C-T is described in ClinVar as [Benign]. Clinvar id is 786748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.807 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00127 (194/152176) while in subpopulation EAS AF= 0.0257 (133/5170). AF 95% confidence interval is 0.0222. There are 5 homozygotes in gnomad4. There are 94 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 194 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXO1 | NM_002015.4 | c.1506G>A | p.Ser502= | synonymous_variant | 2/3 | ENST00000379561.6 | NP_002006.2 | |
FOXO1 | XM_011535008.3 | c.963G>A | p.Ser321= | synonymous_variant | 2/3 | XP_011533310.1 | ||
FOXO1 | XM_011535010.3 | c.795G>A | p.Ser265= | synonymous_variant | 2/3 | XP_011533312.1 | ||
FOXO1 | XM_047430204.1 | c.795G>A | p.Ser265= | synonymous_variant | 2/3 | XP_047286160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXO1 | ENST00000379561.6 | c.1506G>A | p.Ser502= | synonymous_variant | 2/3 | 1 | NM_002015.4 | ENSP00000368880 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 197AN: 152058Hom.: 5 Cov.: 31
GnomAD3 genomes
AF:
AC:
197
AN:
152058
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00259 AC: 650AN: 251290Hom.: 9 AF XY: 0.00272 AC XY: 369AN XY: 135812
GnomAD3 exomes
AF:
AC:
650
AN:
251290
Hom.:
AF XY:
AC XY:
369
AN XY:
135812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00148 AC: 2163AN: 1461848Hom.: 34 Cov.: 32 AF XY: 0.00163 AC XY: 1183AN XY: 727226
GnomAD4 exome
AF:
AC:
2163
AN:
1461848
Hom.:
Cov.:
32
AF XY:
AC XY:
1183
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00127 AC: 194AN: 152176Hom.: 5 Cov.: 31 AF XY: 0.00126 AC XY: 94AN XY: 74378
GnomAD4 genome
AF:
AC:
194
AN:
152176
Hom.:
Cov.:
31
AF XY:
AC XY:
94
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
74
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FOXO1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at